X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (11) 11
humans (8) 8
oncology (7) 7
female (5) 5
adult (4) 4
middle aged (4) 4
breast cancer (3) 3
cell lung-cancer (3) 3
chemotherapy (3) 3
male (3) 3
mutation (3) 3
neoplasms (3) 3
therapy (3) 3
tumors (3) 3
aged (2) 2
animals (2) 2
antineoplastic agents - pharmacology (2) 2
antineoplastic agents - therapeutic use (2) 2
astrocytoma - genetics (2) 2
biomarkers, tumor - genetics (2) 2
brain neoplasms - genetics (2) 2
cancer (2) 2
cancer research (2) 2
carcinoma, non-small-cell lung - drug therapy (2) 2
care and treatment (2) 2
clinical neurology (2) 2
digestive system diseases (2) 2
dna methylation (2) 2
drug resistance, neoplasm (2) 2
endocrine therapy (2) 2
gene expression regulation, neoplastic (2) 2
genes (2) 2
genetic research (2) 2
lung neoplasms - drug therapy (2) 2
medicine & public health (2) 2
mutation - genetics (2) 2
mutations (2) 2
neoadjuvant therapy (2) 2
neoplasm staging (2) 2
neoplasms - drug therapy (2) 2
promoter regions, genetic - genetics (2) 2
sensitivity (2) 2
targeted therapy (2) 2
treatment outcome (2) 2
tumor suppressor protein p53 - genetics (2) 2
urology (2) 2
urology & nephrology (2) 2
19q (1) 1
1p (1) 1
70-gene signature (1) 1
acquired-resistance (1) 1
adjuvant (1) 1
adjuvant chemotherapy (1) 1
adjuvant tamoxifen (1) 1
adjuvant treatment (1) 1
aged, 80 and over (1) 1
amp-activated protein kinase (1) 1
amp-activated protein kinases - physiology (1) 1
amplification (1) 1
amp‐activated protein kinase (1) 1
anaplastic astrocytoma who grade iii (1) 1
anaplastic lymphoma kinase (1) 1
anaplastic oligodendroglial tumors (1) 1
animal tissue (1) 1
anticancer therapy (1) 1
antineoplastic agents, alkylating - therapeutic use (1) 1
article (1) 1
assay (1) 1
association (1) 1
astrocytoma (1) 1
astrocytoma - drug therapy (1) 1
astrocytoma - pathology (1) 1
astrocytoma - radiotherapy (1) 1
binding (1) 1
biochemistry & molecular biology (1) 1
biochemistry, genetics and molecular biology (1) 1
biopsy (1) 1
bladder cancer (1) 1
brain neoplasms - drug therapy (1) 1
brain neoplasms - pathology (1) 1
brain neoplasms - radiotherapy (1) 1
brain tumors (1) 1
breast neoplasms - diagnosis (1) 1
breast neoplasms - genetics (1) 1
breast neoplasms - metabolism (1) 1
breast neoplasms - pathology (1) 1
breast-cancer (1) 1
calcium-calmodulin-dependent protein kinase kinase - antagonists & inhibitors (1) 1
calcium-calmodulin-dependent protein kinase kinase - physiology (1) 1
cancer genomics (1) 1
cancer therapies (1) 1
cancer therapy (1) 1
carcinoma, non-small-cell lung - pathology (1) 1
cell biology (1) 1
cell line, tumor (1) 1
chemotherapy, adjuvant (1) 1
chromosome deletion (1) 1
chromosomes, human, pair 1 - genetics (1) 1
chromosomes, human, pair 19 - genetics (1) 1
clinical investigations (1) 1
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


International Journal of Gynecological Pathology, ISSN 0277-1691, 03/2019, p. 1
Vulvar malignancies are rare and have diverse origins and presentations. The majority of these tumors are squamous cell carcinoma. An ulcerating vulvar tumor... 
Journal Article
European Urology, ISSN 0302-2838, 2015, Volume 69, Issue 3, pp. 384 - 388
Journal Article
The Breast, ISSN 0960-9776, 04/2018, Volume 38, pp. 125 - 131
To evaluate the use of the MammaPrint assay, a 70-gene risk signature for early breast cancers, and to correlate genomic risk stratification with individual... 
Adjuvant chemotherapy | Breast cancer | Genomic test | Risk assessment | Cohort study | MammaPrint | PROGNOSIS-SIGNATURE | 70-GENE SIGNATURE | VALIDATION | MODEL | ADJUVANT | OBSTETRICS & GYNECOLOGY | DECISIONS | THERAPY | ONCOLOGY | Index Medicus
Journal Article
International journal of cancer, ISSN 0020-7136, 2015, Volume 136, Issue 6, pp. 1434 - 1444
The multikinase inhibitor sorafenib is under clinical investigation for the treatment of many solid tumors, but in most cases, the molecular target responsible... 
AMP‐activated protein kinase | metformin | salicylate | sorafenib | non‐small cell lung cancer | Salicylate | Metformin | AMP-activated protein kinase | Sorafenib | Non-small cell lung cancer | non-small cell lung cancer | DRUG | PROTEIN-KINASE | CHEMOTHERAPY | CELL LUNG-CANCER | LKB1-AMPK PATHWAY | DIABETIC-PATIENTS | BREAST-CANCER | IN-VITRO | METABOLISM | ONCOLOGY | GROWTH | Niacinamide - analogs & derivatives | Lung Neoplasms - drug therapy | ras Proteins - genetics | Proto-Oncogene Proteins p21(ras) | Reactive Oxygen Species - metabolism | Humans | Lung Neoplasms - pathology | Lung Neoplasms - congenital | TOR Serine-Threonine Kinases - antagonists & inhibitors | Female | Antineoplastic Agents - pharmacology | Carcinoma, Non-Small-Cell Lung - pathology | Metformin - pharmacology | Proto-Oncogene Proteins - genetics | Drug Synergism | Xenograft Model Antitumor Assays | AMP-Activated Protein Kinases - physiology | Animals | Calcium-Calmodulin-Dependent Protein Kinase Kinase - antagonists & inhibitors | Cell Line, Tumor | Signal Transduction - physiology | Calcium-Calmodulin-Dependent Protein Kinase Kinase - physiology | Mice | Mice, Inbred BALB C | Phenylurea Compounds - pharmacology | Carcinoma, Non-Small-Cell Lung - drug therapy | Mutation | Niacinamide - pharmacology | Clinical trials | Kinases | Disease control | Lung cancer | Index Medicus | Cancer Therapy
Journal Article
International Journal of Cancer, ISSN 0020-7136, 03/2015, Volume 136, Issue 6, pp. 1434 - 1444
Journal Article
Journal Article
NPJ breast cancer, ISSN 2374-4677, 2019, Volume 5, Issue 1, pp. 15 - 8
Immunohistochemically ER-positive HER2-negative (ER+HER2-) breast cancers are classified clinically as Luminal-type. We showed previously that molecular... 
Medical research | Chemotherapy | Breast cancer | Cancer therapies | Clinical outcomes | Tumors
Journal Article
Neuro-Oncology, ISSN 1522-8517, 02/2011, Volume 13, Issue 2, pp. 235 - 241
textabstractOnly a few studies examined the effect of temozolomide (TMZ) in recurrent low-grade astrocytoma (LGA) after surgery, none of which included a... 
Chemotherapy | Glioma | Low-grade astrocytoma | MGMT | Brain tumors | IDH1 | IDH2 | 19q | Temozolomide | TP53 | 1p | Trisomy 7 | temozolomide | PROMOTER HYPERMETHYLATION | MALIGNANT GLIOMA-CELLS | IDH2 MUTATIONS | DIFFUSE ASTROCYTOMAS | trisomy 7 | RANDOMIZED-TRIAL | chemotherapy | CLINICAL NEUROLOGY | PHASE-II TRIAL | brain tumors | ONCOLOGY | ANAPLASTIC OLIGODENDROGLIAL TUMORS | low-grade astrocytoma | glioma | EUROPEAN-ORGANIZATION | REPAIR GENE | O-6-METHYLGUANINE DNA METHYLTRANSFERASE | Astrocytoma - radiotherapy | Trisomy | Follow-Up Studies | Dacarbazine - therapeutic use | Humans | Middle Aged | Male | Promoter Regions, Genetic - genetics | Immunoenzyme Techniques | Tumor Suppressor Protein p53 - genetics | Chromosomes, Human, Pair 19 - genetics | DNA Methylation | Astrocytoma - drug therapy | Dacarbazine - analogs & derivatives | Polymerase Chain Reaction | Adult | Female | Brain Neoplasms - radiotherapy | Chromosomes, Human, Pair 1 - genetics | Astrocytoma - genetics | Chromosome Deletion | Radiotherapy Dosage | Brain Neoplasms - genetics | Isocitrate Dehydrogenase - genetics | Survival Rate | Treatment Outcome | Brain Neoplasms - drug therapy | Mutation - genetics | Antineoplastic Agents, Alkylating - therapeutic use | O-Methylguanine-DNA Methyltransferase - genetics | Biomarkers, Tumor - genetics | DNA, Neoplasm - genetics | Neoplasm Staging | Index Medicus | Clinical Investigations
Journal Article
Journal of Neuro-Oncology, ISSN 0167-594X, 02/2011, Volume 101, Issue 3, pp. 405 - 417
Journal Article